Christopher Paul Desmond

Summary

Publications

  1. ncbi Sustained virological response rates and durability of the response to interferon-based therapies in hepatitis C patients treated in the clinical setting
    C P Desmond
    Department of Gastroenterology, The Alfred Hospital, Melbourne, Vic, Australia
    J Viral Hepat 13:311-5. 2006
  2. ncbi The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid
    Christopher Paul Desmond
    Department of Gastroenterology, The Alfred Hospital, Melbourne, Vic, Australia
    Liver Int 27:1402-8. 2007

Detail Information

Publications2

  1. ncbi Sustained virological response rates and durability of the response to interferon-based therapies in hepatitis C patients treated in the clinical setting
    C P Desmond
    Department of Gastroenterology, The Alfred Hospital, Melbourne, Vic, Australia
    J Viral Hepat 13:311-5. 2006
    ..We can now expect an SVR in over half of the treated patients. Importantly, the response is durable and medium and long-term follow-up of these patients are of low yield and largely unnecessary...
  2. ncbi The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid
    Christopher Paul Desmond
    Department of Gastroenterology, The Alfred Hospital, Melbourne, Vic, Australia
    Liver Int 27:1402-8. 2007
    ..Our aim was to describe the clinical features, course and effect of ursodeoxycholic acid (UDCA) on liver disease in an adult CF population...